Studium Genetics exhibited at the 7th World Congress of the International Federation of Head and Neck Oncologic Societies (IFHNOS), Rome, 21-25 June 2023. Download the Studium Genetics brochure presented at the congress.
ALMACUBE Almacube is the incubator, accelerator and innovation hub of the University of Bologna and Confindustria Emilia Area Centro. TOMA Advanced Biomedical Assays Spa ("TomaLab") is a Lombardy Region-accredited medical testing laboratory with specialized sections in clinical biochemistry and toxicology, microbiology and virology, pathological anatomy, cytogenetics, and medical genetics.
This page is specifically addressed to health professionals. Please follow these simple steps in order to assess the oral carcinoma risk score of your patients based on Studium Genetics proprietary technology (Oral Carcinoma Risk Algorithm, SG-OCRA™). You can order the collection kit directly from our online shop. For further inquiries, please get in touch with our sales department writing an email to sales@studiumgenetics.com. What's in the box: Together with the collection kit you will receive from the distributor: The cost of the collection kit is not inclusive of the analysis of the sample. This will be invoiced to you separately…
Research supporting the revolutionary method developed and patented by Studium Genetics for the assessment of the patient's risk of developing an Oral Squamous Cell Carcinoma (OSCC) has been published in top international peer-reviewed journals. Gissi, D. B., Suàrez-Fernandez, C., Rossi, R., Vitali, F., Marzi Manfroni, A., Gabusi, A., Morandi, L., Balbi, T., Montebugnoli, L., Foschini, M. P., & Tarsitano, A. (2024). Direct healthcare costs of oral cancer: A retrospective study from a tertiary care center. Journal of Cranio-Maxillofacial Surgery. https://doi.org/10.1016/j.jcms.2024.03.002 Gissi DB, Rossi R, Lenzi J, Tarsitano A, Gabusi A, Balbi T, Montebugnoli L, Marchetti C, Foschini MP, Morandi L.
Studium Genetics has developed and patented the Oral Carcinoma Risk Algorithm (SG-OCRA™) method for the early detection of patients at risk to develop Oral Squamous Cells Carcinoma (OSCC) and its precursor, high grade dysplasia, by quantitative DNA methylation analysis using bisulfite Next Generation Sequencing (NGS) in exfoliating brushes of oral mucosa. The markers involved in this invention are a set of 13 genes in which the aberrant methylation pattern is indicative of severe dysplasia and/or OSCC The DNA methylation analysis of 13 genes is eventually used to perform a calculation by using an internally developed and patented algorithm that generates…
Studium Genetics s.r.l. p.IVA 04039021201 PHONE +39 051 032 1925 EMAIL info@studiumgenetics.com ADDRESS via F. Petrarca 2 40136 Bologna (Italy)